跳至主要内容
临床试验/NCT01387243
NCT01387243已完成不适用

Survey on the Pharmacy Follow up of Alli Purchasers

GlaxoSmithKline0 个研究点目标入组 80 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
主要终点
Change in Physical activity

研究概览

简要总结

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

排除标准

  • 未提供

研究组 & 干预措施

60 mg Orlistat

Purchased by consumer

干预措施: Orlistat (Drug)

结局指标

主要结局

Change in Physical activity

时间窗: baseline to 1 year

次要结局

  • Change in dietary behavior(baseline to 1 year)
  • Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)(baseline to 1 year)
  • Satisfaction with management (i.e., results on weight and treatment comfort)(baseline to 1 year)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验